Skip to main content

Table 2 Type and treatment at the time of serious infections

From: Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

 

n = 67

Sites and types of infections, n (%)

- Respiratory tract

30 (45%)

- Herpes zoster

16 (24%)

- Gastrointestinal tract

6 (9%)

- Bacteremia

6 (9%)

- Urinary tract

6 (9%)

- ABSSI

2 (3%)

- Other

1 (2%)

Type of treatment at infection, n (%)

- Induction

29 (43%)

- Maintenance

36 (54%)

- No treatment

2 (3%)

Prednisone dose at the time of infection, median (range)

19 (5–30) mg/day

  1. ABSSI acute bacterial skin and skin structure infections, mg milligrams